About Interleukin-11 receptor subunit alpha
Interleukin-11 receptor subunit alpha (IL11RA) is a protein
from Homo sapiens identified by UniProt accession
Q14626, 422 residues long.
MolForge cross-references it against 0 known binders and
146 disease associations.
Target properties
| Protein name | Interleukin-11 receptor subunit alpha |
| UniProt accession | Q14626 |
| Gene | IL11RA |
| Organism | Homo sapiens |
| Length | 422 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (146)
Diseases linked to this target (Open Targets).
- craniosynostosis and dental anomalies · score 0.77
- craniosynostosis syndrome, autosomal recessive · score 0.55
- Thrombocytopenia · score 0.40
- neoplasm · score 0.39
- craniosynostosis · score 0.37
- body height · score 0.29
- thyroid gland adenocarcinoma · score 0.23
- neuroinflammatory disorder · score 0.23
- appendicular lean mass · score 0.19
- blood protein measurement · score 0.15
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14626-F1 | alphafold | PREDICTED | 81.54 | — |
Amino-acid sequence (422 residues)
MSSSCSGLSR VLVAVATALV SASSPCPQAW GPPGVQYGQP GRSVKLCCPG VTAGDPVSWF RDGEPKLLQG PDSGLGHELV LAQADSTDEG TYICQTLDGA LGGTVTLQLG YPPARPVVSC QAADYENFSC TWSPSQISGL PTRYLTSYRK KTVLGADSQR RSPSTGPWPC PQDPLGAARC VVHGAEFWSQ YRINVTEVNP LGASTRLLDV SLQSILRPDP PQGLRVESVP GYPRRLRASW TYPASWPCQP HFLLKFRLQY RPAQHPAWST VEPAGLEEVI TDAVAGLPHA VRVSARDFLD AGTWSTWSPE AWGTPSTGTI PKEIPAWGQL HTQPEVEPQV DSPAPPRPSL QPHPRLLDHR DSVEQVAVLA SLGILSFLGL VAGALALGLW LRLRRGGKDG SPKPGFLASV IPVDRRPGAP NL
Explore Interleukin-11 receptor subunit alpha with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets